ENTA
Enanta Pharmaceuticals, Inc. · Healthcare · Biotechnology
Momentum inputs (comparable managers): holder breadth 0.0% · share flow +0.8% · net new positions 0.0% — formula
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 56 | -3 | 10.74M | $156.55M | +2 | −5 |
| Q1 2026 | 62 | -2 | 14.86M | $187.69M | +5 | −7 |
| Q4 2025 | 64 | +3 | 16.10M | $253.79M | +3 | — |
| Q3 2025 | 16 | +1 | 7.96M | $95.31M | +2 | −1 |
| Q2 2025 | 12 | 0 | 8.38M | $63.38M | — | — |
| Q1 2025 | 9 | -2 | 4.49M | $24.81M | — | −2 |
| Q4 2024 | 11 | -1 | 4.05M | $23.26M | — | −1 |
| Q3 2024 | 11 | +2 | 4.15M | $43.00M | +2 | — |
| Q2 2024 | 9 | — | 3.87M | $50.19M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (passive) | 1.98M | — | $14.94M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | The Vanguard Group ✦ (passive) | 1.98M | — | $14.94M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | The Vanguard Group ✦ (passive) | 1.98M | — | $14.94M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | BlackRock ✦ (passive) | 1.85M | — | $13.96M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | BlackRock ✦ (passive) | 1.85M | — | $13.96M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (passive) | 1.85M | — | $13.96M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (passive) | 1.85M | — | $13.96M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (passive) | 1.85M | — | $13.96M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (passive) | 1.85M | — | $13.96M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | BlackRock ✦ (passive) | 1.85M | — | $13.96M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | BlackRock ✦ (passive) | 1.85M | — | $13.96M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | BlackRock ✦ (passive) | 1.85M | — | $13.96M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | Millennium Management ✦ | 1.46M | +8.3% | $11.03M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 14 | Marshall Wace ✦ | 857.41K | +0.8% | $6.48M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 15 | Marshall Wace ✦ | 857.41K | +0.8% | $6.48M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 16 | Geode Capital Management ✦ (passive) | 485.80K | -1.7% | $3.67M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 17 | Geode Capital Management ✦ (passive) | 485.80K | -1.7% | $3.67M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 18 | State Street Global Advisors ✦ (passive) | 470.27K | +3.3% | $3.56M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 19 | Renaissance Technologies ✦ | 469.50K | +1.3% | $3.55M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 20 | AQR Capital Management ✦ | 396.11K | +10.9% | $2.99M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 21 | AQR Capital Management ✦ | 396.11K | +10.9% | $2.99M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 22 | AQR Capital Management ✦ | 396.11K | +10.9% | $2.99M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 23 | AQR Capital Management ✦ | 396.11K | +10.9% | $2.99M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 24 | AQR Capital Management ✦ | 396.11K | +10.9% | $2.99M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 25 | D. E. Shaw & Co. ✦ | 282.28K | -26.4% | $2.13M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 26 | D. E. Shaw & Co. ✦ | 282.28K | -26.4% | $2.13M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 27 | Two Sigma Investments ✦ | 78.45K | +0.7% | $593,120 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 28 | Citadel Advisors ✦ | 59.14K | -8.9% | $447,129 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 29 | Fidelity (FMR) ✦ | 1.79K | — | $13,540 | 0.0% | n/c | 1 | SEC ↗ |
| 30 | Fidelity (FMR) ✦ | 1.79K | — | $13,540 | 0.0% | n/c | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 131 holders, 26.72M shares, $290.62M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.